By Kari Williamson
“The divestment of Sandvik Medical Solutions is in line with our strategy to exit operations outside of the defined core businesses. There is a strong industrial logic in combining Orchid and Sandvik Medical Solutions and we are convinced that Sandvik Medical Solutions will have a positive development with its new owners”, says Anders Thelin, President of Sandvik Venture.
Claes Ekström, Board Member in Orchid and Partner at Altor Equity Partners, which owns Orchid, adds: ”The combination of Orchid and Sandvik Medical Solutions will have a unique offering to its customers and become the leading orthopaedic implant supplier globally.”
The divestment is expected to be concluded in March 2012.
Sandvik Medical Solutions saw sales of approximately SEK600 million in 2011, and comprised production units in US and UK with about 550 employees.